162 related articles for article (PubMed ID: 7613473)
1. Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.
Weiler S; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
Protein Sci; 1995 Apr; 4(4):756-64. PubMed ID: 7613473
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.
Weiler S; Carson W; Lee Y; Teplow DB; Kishimoto Y; O'Brien JS; Barranger JA; Tomich JM
J Mol Neurosci; 1993; 4(3):161-72. PubMed ID: 8292489
[TBL] [Abstract][Full Text] [Related]
3. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
Lamontagne S; Potier M
J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of saposin C and B. Complete localization of disulfide bridges.
Vaccaro AM; Salvioli R; Barca A; Tatti M; Ciaffoni F; Maras B; Siciliano R; Zappacosta F; Amoresano A; Pucci P
J Biol Chem; 1995 Apr; 270(17):9953-60. PubMed ID: 7730378
[TBL] [Abstract][Full Text] [Related]
6. Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase.
Qi X; Leonova T; Grabowski GA
J Biol Chem; 1994 Jun; 269(24):16746-53. PubMed ID: 8206997
[TBL] [Abstract][Full Text] [Related]
7. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
[TBL] [Abstract][Full Text] [Related]
8. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
Champagne MJ; Lamontagne S; Potier M
FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
10. Fusogenic domain and lysines in saposin C.
Qi X; Chu Z
Arch Biochem Biophys; 2004 Apr; 424(2):210-8. PubMed ID: 15047193
[TBL] [Abstract][Full Text] [Related]
11. Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.
Qi X; Qin W; Sun Y; Kondoh K; Grabowski GA
J Biol Chem; 1996 Mar; 271(12):6874-80. PubMed ID: 8636113
[TBL] [Abstract][Full Text] [Related]
12. Interaction of saposins, acidic lipids, and glucosylceramidase.
Morimoto S; Kishimoto Y; Tomich J; Weiler S; Ohashi T; Barranger JA; Kretz KA; O'Brien JS
J Biol Chem; 1990 Feb; 265(4):1933-7. PubMed ID: 2298731
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
14. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
[TBL] [Abstract][Full Text] [Related]
15. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin.
Zhao Q; Morales CR
J Biol Chem; 2000 Aug; 275(32):24829-39. PubMed ID: 10818106
[TBL] [Abstract][Full Text] [Related]
18. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
[TBL] [Abstract][Full Text] [Related]
19. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
20. Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.
Fabbro D; Grabowski GA
J Biol Chem; 1991 Aug; 266(23):15021-7. PubMed ID: 1714449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]